I’ve got severe big toe arthritis. The first real trial on big toe arthritis surgery beat waiting. My foot doctor still says I’m not a candidate yet.
Eli Lilly just sued six sellers of retatrutide. The catch is that the drug isn’t approved anywhere, so there is no legitimate version to buy. Whatever these sites are shipping came from outside the drug supply.
What each shot is for, how often it comes around, how to pull your own record, and what that record cannot tell you.
What changed for adults 50 to 74, where the real eligibility list is kept, and why a 53-year-old with a genuine cardiovascular problem still cannot tell whether it includes him.
Moderna’s mFLUSIVA was approved on August 5. The most interesting thing about it is what its own approval failed to demonstrate.
MVX tracks mortality across several cohorts, but nobody has shown that lowering the score improves survival, or what a healthy person should do with the result.
I have three Thorne products in my cabinet. Here is what the P&G Thorne acquisition actually changes, based on the brands bought before it.
When insurance says no, the drug costs what LillyDirect and NovoCare charge, just about wherever you buy it. The prescribing service is the part you can shop, and it runs from about $100 to nearly $1,700 a year.
A trademark, a Netflix series, and about $100,000 a year for a city to keep the certification. The business kept growing while the science underneath it kept shrinking.
ZEUS lowered inflammation exactly as designed and did not cut cardiovascular events. That weakens hs-CRP as something to treat, not as something worth measuring. Update, August 22, 2026: the people behind the colchicine trials have answered ZEUS, and a new UK Biobank analysis sharpens what IL-6 actually predicts. Both are covered at the end of
